Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldFormation Bio
Categories
HQNew York, United States
Founded2017
Latest valuation
Annual Recurring Revenue (ARR)
Funding to date$600M+
Headcount
Profitability
Statusactive
Pricing tierenterprise
DescriptionFormation Bio uses AI to accelerate drug development timelines and de-risk clinical programs through predictive modeling and patient selection. The company raised $372M in a Series D round led by Andreessen Horowitz in 2024.